Tudi analiza WHO kaže na veliko učinkovitost ivermektina pri okužbi s Covid-19

Dr Andrew Hill of the Department of Pharmacology at the University of Liverpool (UK) is currently performing a WHO-commissioned review and meta-analysis of randomized controlled trials of ivermectin against covid. In the following 12-minute video, Dr Hill is presenting his preliminary results, which confirm a highly significant 83% reduction in covid mortality (95% CI 65%-92%).

This result is based on in-hospital trials, so it doesn’t even take into account early ambulatory and prophylactic treatment. The WHO now wants to wait for three more trials, due to be published sometime in January, before issuing an official recommendation. At the end of his presentation, Dr Hill speaks of ivermectin as a potentially “transformational treatment”.

Vir: Swiss Policy Research

One response

  1. Dr. Andrew Hill v predavanju tudi poda morebitne tezave pri podatkih:

    – potential for publication bias – are there other unpublished trials?

    – Several trials were open-label – potential for investigator bias

    Lepo bi bilo, ce bi to v svojem zapisu tudi omenili ne le podali nekriticen naslov. O omejitvah dosedanjega vedenja o ucinkovitosti zdravljena z ivermectin po mojem mnenju najboljse opise naslednji citat z AP fact check zapisa:

    ” Dr. Amesh Adalja, an infectious disease expert at Johns Hopkins University, said most of the research around ivermectin at the moment is made up of anecdotes and studies that are not the gold standard in terms of how to use ivermectin.”


%d bloggers like this: